Condition
Polymyositis clinical trials and research
As of November 12, 2026, Find a Trial lists 7 Polymyositis clinical trials that are recruiting, at sites in 14 countries (most in United States (5), Italy (1), Germany (1)). By phase: Phase 1/2 (2), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 7Clinical trials
- 14Countries
Newest Polymyositis clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Patient-rooted insights to shape myositis science | — | New Orleans, Louisiana | Recruiting | Jan 28, 2026 |
| Understanding how dazukibart works in patients with inflammatory muscle diseases | Phase 3 | Glendale, Arizona and 25 other locations | Recruiting | Nov 21, 2024 |
| Using CAR T-cell therapy to treat severe autoimmune diseases | Phase 1/2 | Rome, Lazio | Recruiting | Nov 12, 2024 |
| Using CAR-T cells to treat autoimmune diseases | Phase 1/2 | Erlangen, Bavaria | Recruiting | Apr 4, 2024 |
| Registry and biorepository for rheumatic diseases | — | New Haven, Connecticut | Recruiting | May 26, 2020 |
| Investigating environmental factors linked to anti-synthetase syndrome | — | Miami, Florida and 7 other locations | Recruiting | Jan 13, 2011 |
| Evaluating causes and effects of myositis in adults and children | — | Atlanta, Georgia and 3 other locations | Recruiting | Jun 20, 2001 |
All recruiting trials (7)
-
Patient-rooted insights to shape myositis science
This global project asks people living with myositis (and their care partners) to share experiences and rank research questions so the community can see which issues matter most.
-
Understanding how dazukibart works in patients with inflammatory muscle diseases
This study is testing how well the medication dazukibart works for people with inflammatory muscle diseases like dermatomyositis and polymyositis to see if it helps reduce muscle inflammation and improve strength.
-
Using CAR T-cell therapy to treat severe autoimmune diseases
This study is testing if a new CAR T-cell therapy can help people with severe autoimmune diseases like lupus and scleroderma feel better.
-
Using CAR-T cells to treat autoimmune diseases
This study is testing a new treatment using modified T cells to see if it can help people with autoimmune diseases by targeting and removing harmful B cells.
-
Registry and biorepository for rheumatic diseases
This study is collecting samples and health information from adults with rheumatic diseases at Yale clinics to help researchers learn more about these conditions and improve future treatments.
-
Investigating environmental factors linked to anti-synthetase syndrome
This study is trying to see if certain environmental factors, like infections or other triggers, might play a role in causing anti-synthetase syndrome in people with myositis.
-
Evaluating causes and effects of myositis in adults and children
This study looks at the causes and effects of myositis in both adults and children to better understand how it affects the immune system and overall health.
Related topics
Quick answers
How many Polymyositis clinical trials are recruiting right now?
7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 14 countries. The most sites are in United States (5 trials), Italy (1 trial), Germany (1 trial), Argentina (1 trial), Bulgaria (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 2, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.